New ITC Investigation Notices for Feb. 19
The International Trade Commission published notices in the Feb. 19 Federal Register on the following antidumping and countervailing duty (AD/CVD) injury, Section 337 patent or other trade proceedings (any notices that warrant a more detailed summary will be in another ITT article):
Sign up for a free preview to unlock the rest of this article
If your job depends on informed compliance, you need International Trade Today. Delivered every business day and available any time online, only International Trade Today helps you stay current on the increasingly complex international trade regulatory environment.
- Certain Selective Thyroid Hormone Receptor-Beta Agonists, Processes for Manufacturing or Relating to Same, and Products Containing Same (ITC Inv. No. 337-TA-1352); Notice of a Commission Determination To Review a Final Initial Determination Finding a Violation of Section 337; Request for Written Submissions on Remedy, the Public Interest, and Bonding (here)
- Recent Trends in U.S. Services Trade: 2025 Annual Report (here)
- Methylene Diphenyl Diisocyanate (MDI) from China; Institution of Antidumping Duty Investigation and Scheduling of Preliminary Phase Investigation (here).